Key Record Dates
ClinicalTrials.gov Identifier: | NCT01933932 |
---|---|
Brief Title: | Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC (SELECT-1) |
First Submitted : | August 29, 2013 |
First Submitted that Met QC Criteria : | August 29, 2013 |
First Posted : | September 2, 2013 (Estimate) |
Results First Submitted : | February 27, 2017 |
Results First Submitted that Met QC Criteria : | August 28, 2017 |
Results First Posted : | August 29, 2017 |
Last Update Submitted that Met QC Criteria : | October 16, 2023 |
Last Update Posted : | October 17, 2023 |